Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 23(21)2022 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-36361923

RESUMEN

Acinetobacter baumannii expresses various virulence factors to adapt to hostile environments and infect susceptible hosts. This study investigated the regulatory network of the BfmRS two-component and AbaIR quorum sensing (QS) systems in the expression of virulence-associated genes in A. baumannii ATCC 17978. The ΔbfmS mutant exhibited a significant decrease in surface motility, which presumably resulted from the low expression of pilT and A1S_0112-A1S_0119 gene cluster. The ΔbfmR mutant displayed a significant reduction in biofilm and pellicle formation due to the low expression of csu operon. The deletion of abaR did not affect the expression of bfmR or bfmS. However, the expression of abaR and abaI was upregulated in the ΔbfmR mutant. The ΔbfmR mutant also produced more autoinducers than did the wild-type strain, suggesting that BfmR negatively regulates the AbaIR QS system. The ΔbfmS mutant exhibited no autoinducer production in the bioassay system. The expression of the A1S_0112-A1S_0119 gene cluster was downregulated in the ΔabaR mutant, whereas the expression of csu operon was upregulated in this mutant with a high cell density. In conclusion, for the first time, we demonstrated that the BfmRS-AbaIR QS system axis regulated the expression of virulence-associated genes in A. baumannii. This study provides new insights into the complex network system involved in the regulation of virulence-associated genes underlying the pathogenicity of A. baumannii.


Asunto(s)
Acinetobacter baumannii , Virulencia/genética , Percepción de Quorum/genética , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Biopelículas , Regulación Bacteriana de la Expresión Génica
2.
Infect Genet Evol ; 58: 232-236, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29307769

RESUMEN

To elucidate the epidemicity of carbapenem-resistant Acinetobacter baumannii (CRAB), we investigated the antimicrobial susceptibility, the genetic basis of antimicrobial resistance, and the ability to form biofilms of 147 CRAB isolates collected between 2013 and 2015 from a Korean hospital based on sequence types (STs). Six different STs were identified: ST191 (n=47) and ST208 (n=36) were clones that had already been identified in the study hospital, whereas ST229 (n=28), ST369 (n=18), ST357 (n=17), and ST552 (n=1) were previously unknown. All the CRAB isolates exhibited an extensively drug-resistance. Twelve isolates, including ST191 and ST208, were resistant to tigecycline, and two were resistant to colistin. All the isolates carried ISAbaI-blaOXA-23 structures. The presence of the armA gene and/or a combination of aminoglycoside-modifying enzyme genes (aacC1, aadA1, aacA4, aphA1, and aphA6) was responsible for high-level resistance to aminoglycosides (minimal inhibitory concentrations≥256mg/L). All the ST229 isolates carried the blaPER-1 gene, whereas all the ST357 and ST369 isolates carried both aacA4 and aadA1. The ST229 isolates exhibited the greatest tendency to form biofilms, whereas the ST369 isolates exhibited significantly less tendency to form biofilms than other isolates. In conclusion, we discovered clonal diversity in the CRAB isolates from the study hospital. The resistant gene profiles and biofilm formation capabilities of the emerging CRAB STs differed from those of the circulating STs. The potential relationship between these genotypic and phenotypic traits and the epidemic capacity of CRAB STs requires further investigation.


Asunto(s)
Infecciones por Acinetobacter/epidemiología , Infecciones por Acinetobacter/virología , Acinetobacter baumannii/efectos de los fármacos , Acinetobacter baumannii/genética , Proteínas Bacterianas/genética , Carbapenémicos/farmacología , Resistencia betalactámica , beta-Lactamasas/genética , Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Genotipo , Humanos , Tipificación de Secuencias Multilocus , Fenotipo
3.
J Microbiol ; 42(2): 103-10, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15357303

RESUMEN

In order to understand the molecular basis of selective expression of stationary-phase genes by RNA polymerase containing sigma38 (Esigma38) in Escherichia coli, we examined transcription from the stationary-phase promoters, katEP, bolAP, hdeABP, csgBAP, and mcbP, in vivo and in vitro. Although these promoters are preferentially recognized in vivo by Esigma38, they are transcribed in vitro by both Esigma38 and Esigma70 containing the major exponential sigma, sigma70. In the presence of high concentrations of glutamate salts, however, only Esigma38 was able to efficiently transcribe from these promoters, which supports the concept that the promoter selectivity of sigma38-containing RNA polymerase is observed only under specific reaction conditions. The examination of 6S RNA, which is encoded by the ssr1 gene in vivo, showed that it reduced Esigma70 activity during the stationary phase, but this reduction of activity did not result in the elevation of Esigma38 activity. Thus, the preferential expression of stationary-phase genes by Esigma38 is unlikely the consequence of selective inhibition of Esigma70 by 6S RNA.


Asunto(s)
Proteínas Bacterianas/metabolismo , ARN Polimerasas Dirigidas por ADN/metabolismo , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Regulación Bacteriana de la Expresión Génica/fisiología , Factor sigma/metabolismo , Transcripción Genética/efectos de los fármacos , Adaptación Fisiológica , Secuencia de Aminoácidos , Fusión Artificial Génica , Proteínas Bacterianas/genética , Bacteriocinas/genética , Bacteriocinas/metabolismo , Catalasa/genética , Catalasa/metabolismo , Inhibidores Enzimáticos/farmacología , Escherichia coli/genética , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Genes Reporteros/genética , Genes Reporteros/fisiología , Ácido Glutámico/farmacología , Técnicas In Vitro , Datos de Secuencia Molecular , Regiones Promotoras Genéticas/fisiología , ARN Bacteriano/análisis , ARN Bacteriano/aislamiento & purificación , ARN Bacteriano/farmacología , ARN Mensajero/análisis , ARN Mensajero/aislamiento & purificación , ARN no Traducido , Transcripción Genética/fisiología , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA